Standard Biotools (LAB) Profit After Tax (2010 - 2026)

Standard Biotools (LAB) has reported Profit After Tax for 17 consecutive years, with -$26.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Profit After Tax rose 20.03% year-over-year to -$26.8 million in Q2 2026; TTM through Jun 2026 was $84.9 million, a 173.49% increase from a year earlier, with the FY2025 full-year figure at -$74.9 million, up 46.07% from the prior year.
• Profit After Tax was -$26.8 million for Q2 2026 at Standard Biotools, down from $127.1 million in the prior quarter.
• Over five years, Profit After Tax peaked at $127.1 million in Q1 2026 and troughed at -$76.3 million in Q1 2022.
• A 5-year average of -$18.9 million and a median of -$28.0 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax plunged 305.33% in 2022 and jumped 588.1% in 2026, its largest moves.
• Over 5 years, Profit After Tax stood at -$20.8 million in 2022, then surged by 264.76% to $34.3 million in 2023, then slumped by 184.75% to -$29.1 million in 2024, then soared by 166.25% to $19.3 million in 2025, then tumbled by 238.76% to -$26.8 million in 2026.
• The last three Profit After Tax figures came in at -$26.8 million (Q2 2026), $127.1 million (Q1 2026), and $19.3 million (Q4 2025), per Business Quant data.